| Date | Research Question / Title | Unique ID | Research Team |
|---|---|---|---|
| March 3, 2021 | What is the risk of COVID-19 acquisition via exposures of the ocular mucosa? | PPE030101-01 ESR | Personal Protective Equipment |
| December 11, 2020 | What is the risk of COVID-19 transmission during AGMP procedures? | PPE120901-01 ESR | Personal Protective Equipment |
| November 10, 2020 | What evidence is available regarding degradation of N95 respirators/masks? | PPE110203-01 ESR | Personal Protective Equipment |
| November 6, 2020 | What is the evidence to support the reprocessing and re-use of N95 respirators by healthcare workers? | PPE110201-01 ESR | Personal Protective Equipment |
| April 17, 2020 | What distinguishes COVID-19 from influenza-like illnesses? | PPE041701-01 ESR | Personal Protective Equipment |
| April 17, 2020 | What is the clinical evidence used to support aerosol generating medical procedures recommendations and guidelines regarding line flow volume or pressure? | PPE041702-01 ESR | Personal Protective Equipment |
